Drugs /
pegylated interferon alfa
Overview
Clinical Trials
Pegylated interferon alfa has been investigated in 2 clinical trials, of which 2 are open and 0 are closed. Of the trials investigating pegylated interferon alfa, 2 are phase 3 (2 open).
BCR-ABL1 Fusion and t(9;22)(q34;q11) are the most frequent biomarker inclusion criteria for pegylated interferon alfa clinical trials.
Chronic myeloid leukemia is the most common disease being investigated in pegylated interferon alfa clinical trials [2].
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.